Director’s Blog One of the most influential trials in cardiology over the past 25 years was the GISSI 1 study, which demonstrated the beneficial effects of administering a medication called streptokinase after a heart attack. 2 GISSI involved more than 11, 000 patients in 176 coronary care units over 17 months. Its total cost was less than $500, 000.

Read >